Leqvio Dosage
Generic name: INCLISIRAN SODIUM 284mg in 1.5mL
Dosage form: injection, solution
Drug class: Miscellaneous antihyperlipidemic agents
Medically reviewed by Drugs.com. Last updated on Feb 17, 2023.
2.1 Recommended Dosage
The recommended dosage of LEQVIO, in combination with maximally tolerated statin therapy, is 284 mg administered as a single subcutaneous injection initially, again at 3 months, and then every 6 months.
If a planned dose is missed by less than 3 months, administer LEQVIO and maintain dosing according to the patient’s original schedule.
If a planned dose is missed by more than 3 months, restart with a new dosing schedule - administer LEQVIO initially, again at 3 months, and then every 6 months.
Assess LDL-C when clinically indicated. The LDL-lowering effect of LEQVIO may be measured as early as 30 days after initiation and anytime thereafter without regard to timing of the dose.
2.2 Important Administration Instructions
LEQVIO should be administered by a healthcare professional.
Inject LEQVIO subcutaneously into the abdomen, upper arm, or thigh. Do not inject in areas of active skin disease or injury, such as sunburns, skin rashes, inflammation, or skin infections.
Inspect LEQVIO visually before use. It should appear clear and colorless to pale yellow. Do not use if particulate matter or discoloration is seen.
Frequently asked questions
- What is the difference between Leqvio and Repatha?
- Can Leqvio be taken without a statin?
- Does Leqvio cause weight gain?
- What is the mechanism of action for Leqvio (inclisiran)?
- Is Leqvio FDA approved as a high cholesterol treatment?
- How is Leqvio injection administered?
- Who is the actor in the Leqvio commercial?
- How does Leqvio work in treating high cholesterol?
- Where can I find the Leqvio FDA package insert?
More about Leqvio (inclisiran)
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antihyperlipidemic agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.